• Placebo-Controlled Double-Blind Trial Validates Mianserin HC

  2026-05-22

  This landmark placebo-controlled, double-blind trial rigorously established the antidepressant efficacy and sleep-enhancing properties of Mianserin HCl in female inpatients with depressive illness. The study's robust methodological approach and use of quantitative mood and sleep assessments provided critical evidence supporting Mianserin HCl as a clinically relevant 5-HT2 receptor antagonist.

• Cl-Amidine Trifluoroacetate Salt: PAD4 Inhibition in Researc

  2026-05-22

  Cl-Amidine (trifluoroacetate salt) enables researchers to dissect PAD4-mediated pathways with precision, driving innovation in cancer and inflammatory disease models. Its robust selectivity transforms experimental workflows, offering reproducible inhibition of histone citrullination and gene expression modulation.

• PKM2 Inhibitor (Compound 3k): Precision Control of Tumor Gly

  2026-05-21

  Explore PKM2 inhibitor (compound 3k) as a selective pyruvate kinase M2 inhibitor that disrupts aerobic glycolysis in cancer cells. This article uniquely examines its translational impact on cancer metabolism and immune modulation, drawing on the latest mechanistic and in vivo insights.

• Docetaxel in Cancer Chemotherapy Research: Applied Workflows

  2026-05-21

  Leverage Docetaxel’s unique microtubule-stabilizing mechanism to dissect cancer cell apoptosis, chemoresistance, and tumor growth inhibition. This guide delivers stepwise workflow enhancements, protocol parameters, and troubleshooting strategies for reproducible oncology research—grounded in the latest mechanistic evidence.

• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Techni

  2026-05-20

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for reproducible, high-yield synthesis of fluorescently labeled RNA probes for research applications such as in situ hybridization and Northern blot hybridization. It should not be used for diagnostic or therapeutic purposes, and is optimized for workflows demanding sensitive and efficient RNA fluorescence detection.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-05-20

  This study uncovers how carcinogen-induced super-enhancer RNA (seRNA-NPCm) promotes metastasis in nasopharyngeal carcinoma (NPC) by activating the NPM1/c-Myc/NDRG1 regulatory axis. The findings provide mechanistic insight into enhancer RNA function in cancer progression and suggest new avenues for biomarker and therapeutic development.

• Aptamer-Based tiRNA Enables Reversible, Precise Gene Silenci

  2026-05-19

  The reference study introduces tiRNA, a novel gene silencing platform that uses an aptamer-reverse complement chimera to block translation without degrading RNA. This approach offers reversibility, high specificity, and safety, representing a significant advance over traditional RNA-targeting strategies and expanding the therapeutic potential for precision gene regulation.

• Kir2.1 Inhibition Reduces PASMC Proliferation in PH Models

  2026-05-19

  This study demonstrates that inhibition of the Kir2.1 potassium channel decreases pulmonary artery smooth muscle cell (PASMC) proliferation and migration, key processes in pulmonary vascular remodeling in pulmonary hypertension (PH). The findings establish a mechanistic link between Kir2.1 activity and activation of the TGF-β1/SMAD2/3 pathway, offering new insights for targeted cardiovascular ion channel research.

• ECL Chemiluminescent Substrate Detection Kit: Hypersensitive

  2026-05-18

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) empowers researchers to achieve low picogram sensitivity in immunoblotting workflows, extending detection windows and reducing background. Its robust performance on both nitrocellulose and PVDF membranes makes it an essential tool for Western blot chemiluminescent detection of scarce proteins in complex biological samples.

• BIIE 0246: Unveiling Y2R Antagonism in Neural-Cardiac Resear

  2026-05-18

  Explore the scientific depth of BIIE 0246, a potent neuropeptide Y Y2 receptor antagonist, and discover how its precision enables advanced neural-cardiac interaction studies. This article uniquely bridges mechanistic insights with practical assay strategies, setting a new standard beyond previous reviews.

• Renalase Drives Aldosterone Production via PMCA4b/cAMP Pathw

  2026-05-17

  This study uncovers a novel mechanism by which renalase stimulates aldosterone synthesis in adrenocortical cells through the PMCA4b/cAMP axis, independent of classical calcium signaling. The findings provide new insight into the regulation of aldosterone and highlight potential targets for treating pathological aldosterone excess.

• Hetero-Galactan from Sanghuangporus vaninii: Structure and H

  2026-05-16

  This study systematically characterizes a novel hetero-galactan (SVP3) isolated from Sanghuangporus vaninii and demonstrates its significant hypolipidemic effects in a mouse model. The research elucidates molecular mechanisms via TLR4/NF-κB pathway modulation and provides a foundation for further exploration of bioactive polysaccharides in metabolic disease intervention.

• BIIE 0246: Applied Workflows for Neuropeptide Y Y2 Receptor

  2026-05-15

  Leverage BIIE 0246 for precise NPY Y2 receptor inhibition in cutting-edge neuroscience and metabolic models. This guide delivers optimized protocols, troubleshooting tips, and translational insights—anchored in recent advances on the adipose-neural axis and arrhythmogenesis.

• Gemcitabine Workflow Optimization in Cancer Research Assays

  2026-05-15

  Gemcitabine’s dual function as a DNA synthesis inhibitor and apoptosis inducer uniquely positions it for high-impact cancer research, from checkpoint signaling to tumor metabolism. This guide translates recent mechanistic breakthroughs into actionable workflows, with troubleshooting and parameterization for robust, reproducible assays.

• Cell Senescence β-Galactosidase Staining Kit: Precision in S

  2026-05-14

  Unlock artifact-free, high-specificity detection of cellular senescence with the Cell Senescence β-Galactosidase Staining Kit. This kit’s optimized workflow supports robust, reproducible assays for drug screening and cell aging research, translating advanced biomarker science into daily lab practice.

11400 records 1/760 page Next 12345 下5页 Last page